Brief: Rallybio Corp - Candid Terminates Merger Agreement With Rallybio On May 3, 2026 - SEC Filing
May 4 (Reuters) - Rallybio Corp RLYB.O: RALLYBIO CORP - CANDID TERMINATES MERGER AGREEMENT WITH RALLYBIO ON MAY 3, 2026 - SEC FILING RALLYBIO CORP - ENTITLED TO $50 MILLION PARENT TERMINATION FEE - SEC FILING RALLYBIO CORP - CANDID TO PAY $50 MILLION TERMINATION FEE PLUS $375,000 IN FEES TO RALLYBIO - SEC FILING Source text: [] Further company coverage: RLYB.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rallybio
See all newsNASDAQ RESUMED AT 08:48 AM
Brief: Rallybio Corporation And Avenzo Therapeutics Announce Merger Agreement To Advance Next-Generation Oncology Therapies And $215 Million Concurrent Private Placement
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:55 AM
U.S. STOCKS ON THE MOVE-Mirum Pharma
U.S. STOCKS ON THE MOVE-Mirum Pharma, eBay, FedEx